Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
€ 1.17
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable analyst view
Data is available to registered users only
Data is available to registered users only
About
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.
Data is available to registered users only
Target Price
The average target price of NANOFH.HE is 2.6 and suggests 125% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i
Data is available to registered users only
